欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
NL/H/1852/001
药品名称
Pantogerolan 20 mg
活性成分
Pantoprazole sodium sesquihydrate 20.0 mg
剂型
Gastro-resistant tablet
上市许可持有人
MR Pharma GmbH
参考成员国 - 产品名称
Netherlands (NL)
互认成员国 - 产品名称
Austria (AT)
Pantoprazol Biosan 20 mg - magensaftresistente Tabletten
Latvia (LV)
Lithuania (LT)
Panzilan 20 mg skrandyje neirios tabletės
Estonia (EE)
PANZILAN
许可日期
2010/11/17
最近更新日期
2024/11/22
药物ATC编码
A02BC02 pantoprazole
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Multiple (Copy) Application
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Non Prescription (including OTC)
附件文件下载
Final SPC
|
Common_Smpc_1852_pantoprazole_20mg_gr_tab_2023_07_24_track
Date of last change:2024/09/06
Final PL
|
NL_H_1852_PIL_06_09_2022_Pantoprazole_cl
Date of last change:2024/09/06
PubAR
|
PAR_1852_DC_pantoprazole_5 apr 2011
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase